Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 29;22(2):53-57.
doi: 10.1298/ptr.R0005. eCollection 2019.

Prevalence of sarcopenia defined using the Asia Working Group for Sarcopenia criteria in Japanese community-dwelling older adults: A systematic review and meta-analysis

Hyuma Makizako  1 , Yuki Nakai  1   2 , Kazutoshi Tomioka  2   3 , Yoshiaki Taniguchi  2   4
Affiliations
Review

Prevalence of sarcopenia defined using the Asia Working Group for Sarcopenia criteria in Japanese community-dwelling older adults: A systematic review and meta-analysis

Hyuma Makizako et al. Phys Ther Res. .

Abstract

The aim of this systematic review and meta-analyses was to calculate the pooled prevalence of sarcopenia based on the Asia Working Group for Sarcopenia (AWGS) criteria among Japanese community-dwelling older adults. Data from 8 studies were used to determine the prevalence of sarcopenia in the overall population and in men; data from 9 studies were used to determine that of women. The pooled prevalence rates of sarcopenia using random-effects models were 9.9% (95% confidence interval [CI], 6.2%-15.4%) overall; 9.8% (95% CI, 6.2%-15.2%) among men; and 10.1% (95% CI, 6.4%-15.5%) among women. These findings would be useful to inform community-based strategies and advanced research addressing sarcopenia prevention.

Keywords: aging; muscle mass; muscle strength; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest to disclose.

Figures

Figure 1.
Figure 1.
Systematic literature review protocol Footnote: AD, Alzheimer's Disease; AWGS, Asian Working Group for Sarcopenia; DM, diabetes mellitus.
Figure 2.
Figure 2.
Forest plots of the prevalence of sarcopenia among the overall participants (n = 7,974) Footnote: CI, confidence interval.
Figure 3.
Figure 3.
Forest plots of the prevalence of sarcopenia stratified by sex Footnote: A: men, B: women. CI, confidence interval.
See this image and copyright information in PMC

References

    1. Rosenberg IH: Summary comments: epidemiological and meth- odological problems in determining nutritional status of older persons. Am J Clin Nutr. 1989; 50: 1231-1233.
    1. Woo J: Sarcopenia. Clin Geriatr Med. 2017; 33: 305-314. - PubMed
    1. Cruz-Jentoft AJ, Baeyens JP, et al.: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39: 412-423. - PMC - PubMed
    1. Chen LK, Liu LK, et al.: Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15: 95-101. - PubMed
    1. Fielding RA, Vellas B, et al.: Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011; 12: 249-256. - PMC - PubMed